Investing
CapEx
Vertex Pharmaceuticals CapEx decreased by 10.7% to $133.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 227.8%, from $40.70M to $133.40M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 16.8% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
An increase signals growth investment or infrastructure modernization; a decrease might suggest cost-cutting or a transition to an asset-light model.
Detailed definition
Funds used by a company to acquire, upgrade, and maintain physical assets such as property, plants, buildings, technolog...
Peer comparison
Hardware-focused tech firms typically have higher CapEx relative to revenue than pure software companies due to manufacturing and supply chain needs.
Metric ID:
capital_expendituresHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $49.84M | $52.52M | $61.72M | $63.60M | $53.30M | $54.20M | $33.60M | $42.10M | $59.60M | $40.60M | $58.10M | $68.40M | $69.00M | $67.70M | $92.60M | $40.70M | $145.70M | $101.80M | $149.40M | $133.40M |
| QoQ Change | — | +5.4% | +17.5% | +3.1% | -16.2% | +1.7% | -38.0% | +25.3% | +41.6% | -31.9% | +43.1% | +17.7% | +0.9% | -1.9% | +36.8% | -56.0% | +258.0% | -30.1% | +46.8% | -10.7% |
| YoY Change | — | — | — | — | +6.9% | +3.2% | -45.6% | -33.8% | +11.8% | -25.1% | +72.9% | +62.5% | +15.8% | +66.7% | +59.4% | -40.5% | +111.2% | +50.4% | +61.3% | +227.8% |
Range$33.60M – $149.40M
CAGR+23.0%
Avg YoY Growth+37.8%
Median YoY Growth+33.1%
CapEx at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's capex?
- Vertex Pharmaceuticals (VRTX) reported capex of $133.40M in Q1 2026.
- How has Vertex Pharmaceuticals's capex changed year-over-year?
- Vertex Pharmaceuticals's capex increased by 227.8% year-over-year, from $40.70M to $133.40M.
- What is the long-term trend for Vertex Pharmaceuticals's capex?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's capex has grown at a 16.8% compound annual growth rate (CAGR), from $235.00M to $437.60M.
- What does capex mean?
- The money spent on long-term physical assets like machinery, data centers, and office buildings.